| Ticker: SEMD | 145000 Northeast 87th Street | |
| Exchange: NASDAQ-National Market | Redmond, Washington 98052 | |
| Industry: Manufacturing | (206) 867-1818 |
| Type of Shares: | Common Shares | Filing Date: | 10/4/96 | |
| U.S. Shares: | 1,850,000 | Offer Date: | 11/19/96 | |
| Non-U.S. Shares: | 0 | Filing Range: | $10.00 - $12.00 | |
| Primary Shares: | 1,529,720 | Offer Price: | $11.00 | |
| Secondary Shares: | 320,280 | Gross Spread: | $0.77 | |
| Offering Amount: | $20,350,000 | Selling: | $0.42 | |
| Expenses: | $850,000 | Reallowance: | $0.10 | |
| Shares Out After: | 5,136,906 |
| Manager | Tier | Phone |
| Piper Jaffray Incorporated | Lead Manager | (612) 342-6000 |
| Needham & Company | Co-manager | (212) 371-8300 |
| Auditor: Ernst & Young | |||||
| Audited Income | Latest Unaudited Income | Prior Unaudited Income | Balance Sheet | ||
| 6/30/96 | 9/30/96 | 9/30/95 | 9/30/96 | ||
| Revenue: | $26.13 | $10.08 | $5.00 | Assets: | $16.54 |
| Net Income: | $1.24 | $0.49 | $0.17 | Liabilities: | $11.27 |
| EPS: | $0.32 | $0.12 | $0.04 | Equity: | $5.27 |
Note: Dollar amounts are in U.S. millions; Audited figures expressed as full year, unaudited figures are partial year | |||||
| Business Description |
| SeaMED Corporation is a leading manufacturer of advanced medical instruments for medical technology companies. SeaMED manufactures durable electronic medical instruments for its customers, often as part of systems that also include single-use components. To assist its customers in developing and commercializing their instruments for manufacture by SeaMED, the company provides a wide range of engineering services and regulatory expertise. In its last fiscal year, SeaMED manufactured or engineered instruments for many established medical technology companies, including Arrow International. Inc., Becton, Dickinson and Company, Johnson & Johnson, Physio-Control Corporation, St. Jude Medical, Inc., Sorin Biomedical Inc. and United States Surgical Corporation. |
| Use of Proceeds |
| The proceeds from the proposed offering will be used for the repayment of outstanding bank indebtedness, payment for cumulative dividends on Preferred Stock, to fund working capital needs and for general corporate purposes. |
©1996 IPO Data Systems, Inc. - All rights reserved.